Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Impact of Clonal Size and High Disease Activity on Clinical Outcomes of Paroxysmal Nocturnal Hemoglobinuria: A Multicenter Registry

Elia Ixel Apodaca Chavez, Jose Luis Alvarez Vera, Moises Xolotl Castillo, Ana Florencia Ramirez, Juan Manuel Perez, Jose Antonio Dela Peña Celaya, Laura Ceja Ramirez, David Solar Cafaggi, Junice Teresita Sosa Romero, Alvaro Aguayo, Efreen Montano Figueroa

Blood (2024) 144 (Supplement 1): 5683.

https://doi.org/10.1182/blood-2024-203775

Published: 2024

Journal Articles

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 6474.

https://doi.org/10.1182/blood-2024-209615

Published: 2024

Journal Articles

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Blood (2024) 144 (Supplement 1): 6452.

https://doi.org/10.1182/blood-2024-198823

Published: 2024

Journal Articles

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

Rubí Alejandra A Orta-Martínez, Fernando J Medina-Olivares, Gregory Abel, Anna Revette, Amar H. Kelkar, Erica O Koranteng, Maria del Campo-Martinez, Efreen Montano Figueroa, Brenda Lizeth Acosta Maldonado, Efrain Aquino-Fernandez, Luis Mario Villela Martinez, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 5205.

https://doi.org/10.1182/blood-2024-208223

Published: 2024

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6697–6698.

https://doi.org/10.1182/blood-2022-162389

Published: 2022

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1436.

https://doi.org/10.1182/blood-2021-151389

Published: 2021

Journal Articles

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1442.

https://doi.org/10.1182/blood-2021-152340

Published: 2021

Journal Articles

Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Therapy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study

Carlos Vallejo, Jun Ho Jang, Carlo Finelli, Efreen Montaño Figueroa, Lalita Norasetthada, Rodrigo T. Calado, Mehmet Turgut, Regis Peffault De Latour, Ulrike Kriemler-Krahn, Jens Haenig, Joan Maier, Phillip Scheinberg

Blood (2021) 138 (Supplement 1): 2174.

https://doi.org/10.1182/blood-2021-147733

Published: 2021

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141943

Published: 2020

Journal Articles

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Guilherme Fleury Perini, MD, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, MD, Brady E Beltran, MD, Denisse A. Castro, MD, Victoria Otero, MD, Mariana Kalmus, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Myrna Candelaria, MDPharmD, Alana Von Glasenapp, MD, Ivan Perdomo, MD, Carolina Feres, MD, Maria Prates, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, Claudia Gajardo, MD, Macarena Alejandra Roa Salinas, Humberto Martínez Cordero, MD, Melani Otañez, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Marcos Di Stefano, MD, Rosio Baena, MD, Juan Antonio Choque, MD, Virginia Abello, MD, Ximena Valladares, MD, Sofia Sanchez, MD, Cristaldo Nancy, MD, Daniela Zambrano, Juan Felipe Lasso, MD, Andrea Noboa, MD, Christine Rojas, MD, Larissa LC Teixeira, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD, Luis Villela Villela, MDMC

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142787

Published: 2020

Journal Articles

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Blood (2019) 134 (Supplement_1): 4121.

https://doi.org/10.1182/blood-2019-127479

Published: 2019

Journal Articles

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Blood (2019) 134 (Supplement_1): 1613.

https://doi.org/10.1182/blood-2019-123841

Published: 2019

Journal Articles

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

Emanuele Angelucci, MD, Junmin Li, Peter L Greenberg, MD, Wu Depei, MD, PhD, Ming Hou, MD, Efreen Montaño Figueroa, PhD, Guadalupe Rodriguez, Xunwei Dong, Jagannath Ghosh, Orna Bornstein, Guillermo Garcia-Manero, MD

Blood (2018) 132 (Supplement 1): 234.

https://doi.org/10.1182/blood-2018-99-111134

Published: 2018

Journal Articles

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Luis Mario VILLELA Martinez, MD, Ana Ramirez-Ibarguen, MD, Efreen Montaño Figueroa, PhD, Montserrat Rojas-Sotelo, MD, Fernando Perez-Jacobo, MD, Gisela B. Gomez-Cruz, MD, Silvia Rivas-Vera, MD, Jorge Duque, MD, Sergio Tena, MD, Yocanxochitl Perfecto-Avalos, MS, Guillermo Ruiz Arguelles, MD, David Gomez-Almaguer, MD, Carlos Best, MD, Arianna Robles-Rodriguez, MD, Alicia Guzman

Blood (2018) 132 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2018-99-118411

Published: 2018

Journal Articles

Effect of Metformin in Patients with ALL Who Express High Levels of the ABCB1 Gene and Its Impact on Survival

Christian Omar Ramos Penafiel, Irma Olarte Carrillo, PhD, Rafael Cerón Maldonado, Humberto Baldemar Castellanos Sinco, MD, Etta Rozen Fuller, MD, Efreen Montaño Figueroa, PhD, Juan Collazo Jaloma, Hematologist, Adolfo Martinez Tovar, PhD

Blood (2017) 130 (Supplement 1): 3885.

https://doi.org/10.1182/blood.V130.Suppl_1.3885.3885

Published: 2017

Journal Articles

Tissue Factor Expression As a Prognostic Marker in Patients with B-Cell Malignant Lymphoma

Carlos Martinez Murillo, MD PhD, Efreen Montaño Figueroa, PhD, Humberto Baldemar Castellanos Sinco, MD, Christian Ramos Peñafiel, MD, Juan Collazo Jaloma, Hematologist, Etzel Camargo Romero, MD

Blood (2017) 130 (Supplement 1): 3700.

https://doi.org/10.1182/blood.V130.Suppl_1.3700.3700

Published: 2017

Journal Articles

A Multicenter Retrospective Experience of Hematologic Neoplasms in Pregnancy

Álvaro Cabrera-García, MD, Samuel Vargas-Trujillo, Alonso Hernández-Company, MD, Carolina Balderas-Delgado, MD, Guillermo Días-Vargas, Espinoza Ramiro, III, Efreen Montaño Figueroa, PhD Hematologist, Everardo Antonio Barragan-Romero, Tito Ramirez-Lozada, Leopoldo Gatica-Galina, Etzel Camargo Romero, MD, Christian Ramos-Peñafiel, Humberto Baldemar Baldemar Castellanos Sinco, MD, Edith Elizalde-Silva, Flor Cruz-Antonio, Andrea Ambriz-Reyes, Victor Manuel Vidal-González

Blood (2017) 130 (Supplement 1): 4716.

https://doi.org/10.1182/blood.V130.Suppl_1.4716.4716

Published: 2017

NARROW

Impact of Clonal Size and High Disease Activity on Clinical Outcomes of Paroxysmal Nocturnal Hemoglobinuria: A Multicenter Registry

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Moral Distress and Burnout Among Hematologists in Mexico: Results of a National Survey

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: Real World Experience in Latin America. A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Therapy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

A Multi-Institutional Validation of the Prognostic and Predictive Value of the Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B- Cell Lymphoma: A Study from the Latin American Working Group for Lymphomas (GELL)

Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

International Prognostic Indexes (IPI, RIPI, NCCN-IPI) for Predicting Overall Survival in Diffuse Large B-Cell Lymphoma Can be Improved By Adding Serum Albumin As Another Predictive Factor. Retrospective Study of the Mexican Study Group in Lymphoma from a Database of 855 Patients

Effect of Metformin in Patients with ALL Who Express High Levels of the ABCB1 Gene and Its Impact on Survival

Tissue Factor Expression As a Prognostic Marker in Patients with B-Cell Malignant Lymphoma

A Multicenter Retrospective Experience of Hematologic Neoplasms in Pregnancy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only